Taylor's Library

Normal view MARC view ISBD view

Antipsychotic trials in schizophrenia : the CATIE project / edited by T. Scott Stroup, Jeffrey A. Lieberman.

Contributor(s): Stroup, T. Scott, 1960- | Lieberman, Jeffrey A, 1948-.
Series: Cambridge medicine: Publisher: Cambridge : Cambridge University Press, 2010Description: xvii, 312 p. : ill. ; 24 cm.ISBN: 9780521895330 (hbk.).Subject(s): CATIE Project | Antipsychotic drugs -- Testing | Schizophrenia -- ChemotherapyDDC classification: 616.89806
Contents:
Machine generated contents note: Introduction: Rationale for an independent, pragmatic study of antipsychotic treatments Jeffrey Lieberman; 1. Study design and protocol development process Scott Stroup, Joe McEvoy and Jeffrey Lieberman; 2. Statistical considerations Sonia Davis and Gary Koch; 3. Efficacy and effectiveness Joe McEvoy, Scott Stroup and Jeffrey Lieberman; 4. Measures of global effectiveness, cost-effectiveness Bob Rosenheck; 5. Quality of life and recovery Marvin Swartz; 6. Neurocognition Rich Keefe; 7. Vocational outcomes Sandra Resnick et al.; 8. Family outcomes Deborah Perlick et al.; 9. Neurologic side effects Stan Caroff, Del Miller and Bob Rosenheck; 10. Metabolic side effects and risk of cardiovascular disease Jonathan Meyer, Don Goff and Joe McEvoy; 11. Substance abuse Fred Reimherr and Marvin Swartz; 12. Violence Jeff Swanson and Richard van Dorn; 13. Genetics Patrick Sullivan; 14. Human subjects considerations Scott Stroup, Scott Kim and Paul Appelbaum; 15. Pharmacokinetics Bruce Pollock; 16. Implications of the CATIE project on research design and implementation Scott Stroup and Jeffrey Lieberman; 17. Conclusions-impact of the study and implications for dissemination, practice and policy formation Scott Stroup, Bob Rosenheck and Jeffrey Lieberman; Index.
Item type Current location Call number Copy number Status Notes Date due Barcode
SOM Main Collection Clinical School
616.89806 ANT 2010 (Browse shelf) 1 Available SOMxx,33001,03,GR 5000122221
Browsing Clinical School Shelves Close shelf browser
616.895 PRA 2010 Practical management of bipolar disorder / 616.898 SCH 2011 Schizophrenia / 616.898 SEC 2010 Secondary schizophrenia / 616.89806 ANT 2010 Antipsychotic trials in schizophrenia : 616.9 BAN 2006 Infection : 616.9 BAN 2006 Infection : 616.9 BAN 2006 Infection :

Includes bibliographical references and index.

Machine generated contents note: Introduction: Rationale for an independent, pragmatic study of antipsychotic treatments Jeffrey Lieberman; 1. Study design and protocol development process Scott Stroup, Joe McEvoy and Jeffrey Lieberman; 2. Statistical considerations Sonia Davis and Gary Koch; 3. Efficacy and effectiveness Joe McEvoy, Scott Stroup and Jeffrey Lieberman; 4. Measures of global effectiveness, cost-effectiveness Bob Rosenheck; 5. Quality of life and recovery Marvin Swartz; 6. Neurocognition Rich Keefe; 7. Vocational outcomes Sandra Resnick et al.; 8. Family outcomes Deborah Perlick et al.; 9. Neurologic side effects Stan Caroff, Del Miller and Bob Rosenheck; 10. Metabolic side effects and risk of cardiovascular disease Jonathan Meyer, Don Goff and Joe McEvoy; 11. Substance abuse Fred Reimherr and Marvin Swartz; 12. Violence Jeff Swanson and Richard van Dorn; 13. Genetics Patrick Sullivan; 14. Human subjects considerations Scott Stroup, Scott Kim and Paul Appelbaum; 15. Pharmacokinetics Bruce Pollock; 16. Implications of the CATIE project on research design and implementation Scott Stroup and Jeffrey Lieberman; 17. Conclusions-impact of the study and implications for dissemination, practice and policy formation Scott Stroup, Bob Rosenheck and Jeffrey Lieberman; Index.